Trigeminal Neuralgia: Clinical Trials

10 trials for Trigeminal Neuralgia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Unknown 2, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Trigeminal Neuralgia: new trials by email Literature Review of Trigeminal Neuralgia trials Research Report on Trigeminal Neuralgia

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal Neuralgia
Oxcarbazepine, Carbamazepine - Trigeminal Neuralgia
Phase 4Active not recruitingJinnah Postgraduate Medical Centre1222024-09-212025-03-04
OnabotulinumtoxinA for Trigeminal Neuralgia
OnabotulinumtoxinA 100 UNT [Botox], Sodium Chloride 0.9% for Injection, Preservative Free - Trigeminal Neuralgia
Phase 4RecruitingStanford University202024-06-012026-01-22
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
Oxcarbazepine, Carbamazepine - Trigeminal Neuralgia
Phase 4UnknownPostgraduate Institute of Dental Sciences Rohtak1322021-09-182021-10-15
5% Lidocaine-medicated Plaster for the Treatment of Trigeminal Neuralgia
5% lidocaine medicated plaster, vehicle plaster - Trigeminal Neuralgia
Phase 4CompletedBeijing Tiantan Hospital2262021-05-012023-03-14
Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia
Galcanezumab - Trigeminal Neuralgia, Glossopharyngeal Neuralgia
Phase 4CompletedDuke University262020-07-242026-02-02
Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia
Oxtellar XR 150Mg Extended Release Tablet - Trigeminal Neuralgia
Phase 4WithdrawnUniversity of Colorado, Denver2018-12-142019-11-01
(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist
Botulinum toxin type A - Migraine
Phase 4CompletedMassachusetts General Hospital372017-12-012025-03-24
Postoperative Analgesia in Patients With Microvascular Decompression
Ketamine, scalp nerve block, ondansetron - Trigeminal Neuralgia
Phase 4UnknownXiangya Hospital of Central South University902017-05-152018-05-15
Surface Acoustic Wave Ultrasound in Trigeminal Neuralgia Pain
Low Intensity Low Frequency Surface Acoustic Wave Ultrasound (PainShield™) - Trigeminal Neuralgia, Tic Douloureux
Phase 4CompletedSheba Medical Center162011-11-012012-12-27
A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)
COA566 - Malaria
Phase 4CompletedNovartis140752010-11-012014-02-10

Narrower conditions

Glossopharyngeal Nerve Diseases (1)  ·  Malaria (1)  ·  Migraine Disorders (1)

Broader conditions

Cranial Nerve Diseases (10)  ·  Facial Nerve Diseases (10)  ·  Facial Neuralgia (10)  ·  Mouth Diseases (10)  ·  Nervous System Diseases (10)  ·  Stomatognathic Diseases (10)  ·  Trigeminal Nerve Diseases (10)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Headache Disorders (1)  ·  Headache Disorders, Primary (1)  ·  Infections (1)  ·  Mosquito-Borne Diseases (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)

Interventions

Oxcarbazepine (3)  ·  Botulinum Toxins, Type A (2)  ·  Carbamazepine (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Injections (1)  ·  Ketamine (1)  ·  Ondansetron (1)  ·  Sodium Chloride (1)  ·  Sufentanil (1)  ·  galcanezumab (1)  ·  zileuton (1)

Sponsors

Beijing Tiantan Hospital (1)  ·  Duke University (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Massachusetts General Hospital (1)  ·  Novartis (1)  ·  Postgraduate Institute of Dental Sciences Rohtak (1)  ·  Sheba Medical Center (1)  ·  Stanford University (1)  ·  University of Colorado, Denver (1)  ·  Xiangya Hospital of Central South University (1)

Countries

United States (3)  ·  China (2)  ·  Burkina Faso (1)  ·  India (1)  ·  Israel (1)  ·  Pakistan (1)

Top investigators

Dr. Rizwana Malahat Ahmad, MBBS (1)  ·  Fang Luo (1)  ·  Jacquelyn Bainbridge, PharmD (1)  ·  Manuel Zwecker, MD (1)  ·  Meredith Barad, MD (1)  ·  Sweta Sengupta, MD (1)  ·  William G. Austen, MD (1)  ·  Xie Yongqiu (1)

Results publications

PMID 24215306, PMID 34341037, PMID 39193836